Cargando…
A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2
The generation of induced pluripotent stem cells (iPSCs) from differentiated cells following forced expression of OCT4, KLF4, SOX2, and C-MYC (OKSM) is slow and inefficient, suggesting that transcription factors have to overcome somatic barriers that resist cell fate change. Here, we performed an un...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939549/ https://www.ncbi.nlm.nih.gov/pubmed/26947976 http://dx.doi.org/10.1016/j.stemcr.2016.02.004 |
_version_ | 1782442022145097728 |
---|---|
author | Borkent, Marti Bennett, Brian D. Lackford, Brad Bar-Nur, Ori Brumbaugh, Justin Wang, Li Du, Ying Fargo, David C. Apostolou, Effie Cheloufi, Sihem Maherali, Nimet Elledge, Stephen J. Hu, Guang Hochedlinger, Konrad |
author_facet | Borkent, Marti Bennett, Brian D. Lackford, Brad Bar-Nur, Ori Brumbaugh, Justin Wang, Li Du, Ying Fargo, David C. Apostolou, Effie Cheloufi, Sihem Maherali, Nimet Elledge, Stephen J. Hu, Guang Hochedlinger, Konrad |
author_sort | Borkent, Marti |
collection | PubMed |
description | The generation of induced pluripotent stem cells (iPSCs) from differentiated cells following forced expression of OCT4, KLF4, SOX2, and C-MYC (OKSM) is slow and inefficient, suggesting that transcription factors have to overcome somatic barriers that resist cell fate change. Here, we performed an unbiased serial shRNA enrichment screen to identify potent repressors of somatic cell reprogramming into iPSCs. This effort uncovered the protein modifier SUMO2 as one of the strongest roadblocks to iPSC formation. Depletion of SUMO2 both enhances and accelerates reprogramming, yielding transgene-independent, chimera-competent iPSCs after as little as 38 hr of OKSM expression. We further show that the SUMO2 pathway acts independently of exogenous C-MYC expression and in parallel with small-molecule enhancers of reprogramming. Importantly, suppression of SUMO2 also promotes the generation of human iPSCs. Together, our results reveal sumoylation as a crucial post-transcriptional mechanism that resists the acquisition of pluripotency from fibroblasts using defined factors. |
format | Online Article Text |
id | pubmed-4939549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-49395492016-07-19 A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2 Borkent, Marti Bennett, Brian D. Lackford, Brad Bar-Nur, Ori Brumbaugh, Justin Wang, Li Du, Ying Fargo, David C. Apostolou, Effie Cheloufi, Sihem Maherali, Nimet Elledge, Stephen J. Hu, Guang Hochedlinger, Konrad Stem Cell Reports Article The generation of induced pluripotent stem cells (iPSCs) from differentiated cells following forced expression of OCT4, KLF4, SOX2, and C-MYC (OKSM) is slow and inefficient, suggesting that transcription factors have to overcome somatic barriers that resist cell fate change. Here, we performed an unbiased serial shRNA enrichment screen to identify potent repressors of somatic cell reprogramming into iPSCs. This effort uncovered the protein modifier SUMO2 as one of the strongest roadblocks to iPSC formation. Depletion of SUMO2 both enhances and accelerates reprogramming, yielding transgene-independent, chimera-competent iPSCs after as little as 38 hr of OKSM expression. We further show that the SUMO2 pathway acts independently of exogenous C-MYC expression and in parallel with small-molecule enhancers of reprogramming. Importantly, suppression of SUMO2 also promotes the generation of human iPSCs. Together, our results reveal sumoylation as a crucial post-transcriptional mechanism that resists the acquisition of pluripotency from fibroblasts using defined factors. Elsevier 2016-03-03 /pmc/articles/PMC4939549/ /pubmed/26947976 http://dx.doi.org/10.1016/j.stemcr.2016.02.004 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Borkent, Marti Bennett, Brian D. Lackford, Brad Bar-Nur, Ori Brumbaugh, Justin Wang, Li Du, Ying Fargo, David C. Apostolou, Effie Cheloufi, Sihem Maherali, Nimet Elledge, Stephen J. Hu, Guang Hochedlinger, Konrad A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2 |
title | A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2 |
title_full | A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2 |
title_fullStr | A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2 |
title_full_unstemmed | A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2 |
title_short | A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2 |
title_sort | serial shrna screen for roadblocks to reprogramming identifies the protein modifier sumo2 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939549/ https://www.ncbi.nlm.nih.gov/pubmed/26947976 http://dx.doi.org/10.1016/j.stemcr.2016.02.004 |
work_keys_str_mv | AT borkentmarti aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT bennettbriand aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT lackfordbrad aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT barnurori aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT brumbaughjustin aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT wangli aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT duying aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT fargodavidc aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT apostoloueffie aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT cheloufisihem aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT maheralinimet aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT elledgestephenj aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT huguang aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT hochedlingerkonrad aserialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT borkentmarti serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT bennettbriand serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT lackfordbrad serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT barnurori serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT brumbaughjustin serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT wangli serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT duying serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT fargodavidc serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT apostoloueffie serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT cheloufisihem serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT maheralinimet serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT elledgestephenj serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT huguang serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 AT hochedlingerkonrad serialshrnascreenforroadblockstoreprogrammingidentifiestheproteinmodifiersumo2 |